Results 31 to 40 of about 397 (134)

Comparing the Efficacy of Platelet Rich Plasma (PRP) vs. Topical Minoxidil (5%) as Synergistic Treatment in Patients Receiving Oral Finasteride for Androgenic Alopecia

open access: yesPakistan Journal of Medical Research, 2022
Objective: To compare the efficacy of platelet rich plasma (PRP) vs. topical Minoxidil (5%) as synergistic treatments in patients receiving oral Finasteride for androgenic alopecia. Study type, settings & duration: A comparative cross sectional study
Rozeena Tumrani   +3 more
doaj   +2 more sources

Androgenic Alopecia and Homoeopathic Management

open access: yesInternational Journal of Research and Review, 2023
Androgenic alopecia also known as pattern hair loss or male hormonal alopecia affects both men and women. This has a huge psychological impact on patients, regardless of age or phase of baldness. Homeopathy is a system of treatment that considers the psychological and pathological effects of treating people.
Sreevidhya JS   +2 more
openaire   +1 more source

Stauntonia hexaphylla Extract Ameliorates Androgenic Alopecia by Inhibiting Androgen Signaling in Testosterone-induced Alopecia Mice

open access: yesIranian Journal of Pharmaceutical Research, 2023
Background: Stauntonia hexaphylla has been a traditional folk remedy for alleviating fever and providing anti-inflammatory properties. Androgenetic alopecia (AGA) is the most common form mediated by the presence of the dihydrotestosterone (DHT). Objectives: In this study, we evaluated the effects of an extract of S.
Hong, Geum-Lan   +4 more
openaire   +2 more sources

Optimization of photobiomodulation therapy for spinal cord injury: A review

open access: yesPhotochemistry and Photobiology, EarlyView.
Photobiomodulation (PBM) therapy in the red and near‐infrared range can significantly modulate the secondary injury response and promote the reparative and regenerative potential of neural tissue after spinal cord injury (SCI). At present, due to the nature of delivery methods, the most effective dose and irradiance at the injury site to optimize ...
Isabella K. M. Drew   +3 more
wiley   +1 more source

Dermatological Adverse Events Associated With Lapatinib Treatment in Dogs With Urothelial Carcinoma: A Retrospective Study

open access: yesVeterinary Dermatology, EarlyView.
Lapatinib is widely used in human oncology; however, dermatological adverse events (DAEs) are common and have been correlated with treatment efficacy. In veterinary medicine, lapatinib use in combination with piroxicam has been shown to be effective in treating canine urothelial carcinoma (UC); however, the incidence and prognostic significance of DAEs
Kosuke Horita   +3 more
wiley   +1 more source

Advances of Congenital Alopecia/Hypotrichosis in Genetics Research

open access: yes罕见病研究, 2023
Congenital alopecia/hypotrichosis is a rare group of monogenic genetic hair disorders characterized by congenital limited or diffuse hair loss and scarcity, without any effective treatment.
CUI Can, CHEN Xi, WEI Aihua
doaj   +1 more source

Androgenic alopecia in postmenopausal ovarian hyperthecosis

open access: yesJournal of Obstetrics and Gynaecology, 2011
A 70-year-old woman presented with a 5-year history of progressive hirsutism and baldness. She had her menarche at age of 13 years and had had normal periods from then until the menopause (at age o...
K, Ashawesh, M M, Aghilla, H S, Randeva
openaire   +2 more sources

A Theoretical Model for the Treatment of Androgenetic Alopecia Using the STEAP3 Protein, and the Genetic Challenges of Treating AGA

open access: yesHealth Science Reports, Volume 9, Issue 6, June 2026.
ABSTRACT Background and Aims Androgenetic alopecia (AGA) is a prevalent condition. The treatment methods currently available for this condition have limited potential (minoxidil) and side effects with long‐term therapy that affect the physiology of the male population (5α‐reductase inhibitors).
Ignacy Klemens Młodzianowski   +4 more
wiley   +1 more source

The Relationship of Androgenic Alopecia and Opium Consumption in Men: A Comparative Study

open access: yesمجله دانشکده پزشکی اصفهان, 2017
Background: Androgenic alopecia (AGA) is one of the most common problems among men; in some societies, 50 percent of 50-years-old men are involved. In the past, opium versions of therapeutic compounds for the treatment of hair loss were used.
Jalal Moloudi   +5 more
doaj  

Effect of recombinant collagen 17 spray on male androgenic alopecia

open access: yesPifu-xingbing zhenliaoxue zazhi
[Objective] To observe the effect of recombinant collagen 17 spray on male androgenic alopecia. [Methods] From September 2024 to December 2024, 30 men with androgenic alopecia were treated with recombinant collagen 17 spray twice daily at the dermatology
SHANG Zhiwei   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy